MedTrace Logo

Sacral Neuromodulation as Treatment for Fecal Incontinence

NCT03825575 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-04-05

No results posted yet for this study

Summary

The objective of this study is to investigate if low level laser therapy will do more good than harm for patients with severe refractory fecal incontinence. It is a proof of concept study without a placebo arm.

Conditions

  • Fecal Incontinence

Interventions

DEVICE

Low level laser therapy (LLLT)

A 3 week treatment period with a total of 8 treatments of 1 hour over the sacral spinal cord

Sponsors & Collaborators

Principal Investigators

  • Jihong Chen, MD PhD · McMaster University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-08
Primary Completion
2025-02-01
Completion
2027-02-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03825575 on ClinicalTrials.gov